Adriano Alatri

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


128 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1994 | 1993 |
2024
 
Clinical evolution of patients with lower extremity peripheral artery disease during the COVID-19 pandemic (the COVID-PAD study).
Buso G., Lanzi S., Berchtold A., Deglise S., Alatri A., Calanca L., Mazzolai L., 2024/11. VASA. Zeitschrift fur Gefasskrankheiten, 53 (6) pp. 378-387. Peer-reviewed.
[DOI][Pmid][serval:BIB_08B73304D33E]
2023
 
Maladie thromboembolique veineuse : démarche diagnostique et suivi [Venous thromboembolic disease : diagnostic pathways and follow-up]
Vecchio M., Porceddu E., Mazzolai L., Alatri A., 2023/12/06. Revue medicale suisse, 19 (853) pp. 2278-2283. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3824D87A2A23]
 
Prise en charge de la maladie aortique : l’importance d’une filière des soins [Management of aortic disease: the importance of an organized care network]
Zehani C.E., Deglise S., Kirsch M., Monney P., Calanca L., Mazzolai L., Alatri A., 2023/12/06. Revue medicale suisse, 19 (853) pp. 2292-2297. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_539D4D5BA4EE]
2022
 
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function.
Mazzolai L., Ageno W., Alatri A., Bauersachs R., Becattini C., Brodmann M., Emmerich J., Konstantinides S., Meyer G., Middeldorp S. et al., 2022/05/27. European journal of preventive cardiology, 29 (8) pp. 1248-1263. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F5D5D4A9EECC]
In postmenopausal women, lower limb peripheral arterial disease, assessed by ankle-brachial index, may be a strong predictor of cardiovascular risk.
Buso G., Darioli R., Calanca L., Depairon M., Schwitter J., Mazzolai L., Alatri A., 2022/05. European journal of internal medicine, 99 pp. 63-69. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_272643BEC9E7]
2021
Chez qui effectuer un dépistage de l’anévrisme de l’aorte abdominale ? [Who do you screen for an abdominal aortic aneurysm ?]
Staubli S., Mazzolai L., Fresa M., Déglise S., Alatri A., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2132-2134. Peer-reviewed.
[URN][Pmid][serval:BIB_8DF73853774D]
Maladie thromboembolique veineuse et grossesse : diagnostic, traitement et suivi [Venous thromboembolic disease during pregnancy : diagnosis, treatment and follow-up]
Vecchio M., Guenot C., Staubli S., Gavillet M., Alberio L., Mazzolai L., Alatri A., 2021/12/08. Revue medicale suisse, 17 (762) pp. 2135-2138. Peer-reviewed.
[URN][Pmid][serval:BIB_E4837FC4238A]
 
Progress in aorta and peripheral cardiovascular disease research.
Mazzolai L., Alatri A., Rivière A.B., De Carlo M., Heiss C., Espinola-Klein C., Schlager O., Sillesen H., Staub D., Rodriguez-Palomares J.F. et al., 2021/07/27. Cardiovascular research, 117 (9) pp. 2045-2053. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E6860B14DD9F]
 
Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation.
Fernández-Capitán C., Rodriguez Cobo A., Jiménez D., Madridano O., Ciammaichella M., Usandizaga E., Otero R., Di Micco P., Moustafa F., Monreal M. et al., 2021/01. Research and practice in thrombosis and haemostasis, 5 (1) pp. 168-178. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0CAAA6F3FFBC]
2020
 
Clinical history of cancer‐associated splanchnic vein thrombosis
Valeriani Emanuele, Di Nisio Marcello, Riva Nicoletta, Caiano Lucia Maria, Porreca Ettore, Bang Soo Mee, Beyer-Westendorf Jan, Sartori Maria Teresa, Barillari Giovanni, Santoro Rita et al., 2020/12/11. Journal of Thrombosis and Haemostasis.
[DOI][Pmid][serval:BIB_75B2F4F3B913]
 
Why optional inferior vena cava filters are not always retrieved? A real world 19 years experience in a Swiss tertiary care university hospital.
Buso G., Alatri A., Calanca L., Fresa M., Qanadli S.D., Pesavento R., Mazzolai L., 2020/06. European journal of internal medicine, 76 pp. 64-70. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C6FA69294D2C]
Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis.
Delluc A., Miranda S., Exter P.D., Louzada M., Alatri A., Ahn S., Monreal M., Khorana A., Huisman M.V., Wells P.S. et al., 2020/05. Haematologica, 105 (5) pp. 1436-1442. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_74D2429B6E35]
 
The Bleeding Risk in Antithrombotic Therapies: A Narrative Review.
Alatri A., Mazzolai L., 2020. Current vascular pharmacology, 18 (3) pp. 237-248. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6B648DA7FA0E]
2019
Artériopathie oblitérante des membres inférieurs : complications locales et systémiques [Lower extremity peripheral artery disease : local and systemic complications]
Calanca L., Alatri A., Lanzi S., Deglise S., Mazzolai L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2247-2250. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6E343A74E778]
Artériopathie oblitérante des membres inférieurs : nouveautés dans la thérapie médicamenteuse [Patient with lower extremity artery disease : news in therapeutic approach]
Maufus M., Alatri A., Fresa M., Erdmann A., Mazzolai L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2242-2246. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5AB3C337B5CF]
 
Patient adherence to rivaroxaban in deep vein thrombosis, a cohort study in Switzerland: quantitative results.
Dotta-Celio J., Alatri A., Locatelli I., Salvi M., Bugnon O., Schneider M.P., Mazzolai L., 2019/12. International journal of clinical pharmacy, 41 (6) pp. 1625-1633. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5981370ECFEE]
EANM guideline for ventilation/perfusion single-photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond.
Bajc M., Schümichen C., Grüning T., Lindqvist A., Le Roux P.Y., Alatri A., Bauer R.W., Dilic M., Neilly B., Verberne H.J. et al., 2019/11. European journal of nuclear medicine and molecular imaging, 46 (12) pp. 2429-2451. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1FAAAF83D6FE]
 
Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database.
Fuentes H.E., Tafur A.J., Caprini J.A., Alatri A., Trujillo-Santos J., Farge-Bancel D., Rosa V., Font L., Vilaseca A., Monreal M. et al., 2019/06. International angiology, 38 (3) pp. 173-184. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9723814C34FE]
 
Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry.
Mastroiacovo D., Dentali F., di Micco P., Maestre A., Jiménez D., Soler S., Sahuquillo J.C., Verhamme P., Fidalgo Á., López-Sáez J.B. et al., 2019/02. The European respiratory journal, 53 (2). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CCC8AB494062]
2018
 
Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function.
Mazzolai L., Aboyans V., Ageno W., Agnelli G., Alatri A., Bauersachs R., Brekelmans MPA, Büller H.R., Elias A., Farge D. et al., 2018/12/14. European heart journal, 39 (47) pp. 4208-4218. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_84719A556092]
Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.
Senzolo M., Riva N., Dentali F., Rodriguez-Castro K., Sartori M.T., Bang S.M., Martinelli I., Schulman S., Alatri A., Beyer-Westendorf J. et al., 2018/08/15. Clinical and translational gastroenterology, 9 (8) p. 176. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62CA3247C1D6]
 
Derivation and Validation of a Prediction Model for Risk Stratification of Post-Thrombotic Syndrome in Elderly Patients with a First Deep Vein Thrombosis.
Méan M., Limacher A., Alatri A., Aujesky D., Mazzolai L., 2018/08. Thrombosis and haemostasis, 118 (8) pp. 1419-1427. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2DD10698DBF8]
 
Suitability for catheter-directed thrombolysis in patients with acute lower extremity deep vein thrombosis according to various international consensus guidelines.
Stefanescu A., Alatri A., Périard D., Kucher N., Mazzolai L., Engelberger R.P., 2018/05. Thrombosis research, 165 pp. 112-115. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B1333077E69B]
 
Thrombose veineuse profonde
Alatri Adriano, Ney Barbara, Fresa Marco, Erdmann Andreas, 2018/05/01. Info@herz+gefass.
[serval:BIB_BD119EAE10B9]
2017
 
Thromboangéite oblitérante :notions pour la pratique [Thromboangiitis obliterans: notions for practice]
Calanca L., Alatri A., Krieger C., Corpataux J.M., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2129-2133. Peer-reviewed.
[Pmid][serval:BIB_651B5138D43F]
 
The Modified Ottawa Score and Clinical Events in Hospitalized Patients with Cancer-Associated Thrombosis from the Swiss VTE Registry.
Alatri A., Mazzolai L., Kucher N., Aujesky D., Beer J.H., Baldi T., Banyai M., Hayoz D., Kaeslin T., Korte W. et al., 2017/11. Seminars in thrombosis and hemostasis, 43 (8) pp. 871-876. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9C95354B5C13]
 
Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry.
Alatri A., Mazzolai L., Font C., Tafur A., Valle R., Marchena P.J., Ballaz A., Tiraferri E., Font L., Monreal M. et al., 2017/07/26. Thrombosis and haemostasis, 117 (8) pp. 1630-1636. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1A02DFB51DEB]
 
The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site.
Mahé I., Chidiac J., Bertoletti L., Font C., Trujillo-Santos J., Peris M., Pérez Ductor C., Nieto S., Grandone E., Monreal M. et al., 2017/03. The American journal of medicine, 130 (3) pp. 337-347. Peer-reviewed.
[DOI][Pmid][serval:BIB_AECE4D25C507]
 
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens.
Trujillo-Santos J., Di Micco P., Dentali F., Douketis J., Díaz-Peromingo J.A., Núñez M.J., Cañas I., Mastroiacovo D., Saraiva de Sousa M., Monreal M. et al., 2017/01/26. Thrombosis and haemostasis, 117 (2) pp. 382-389. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9472639B8AAF]
2016
Intérêt de l’échographie de contraste aux microbulles en médecine vasculaire [Relevance of contrast ultrasound with microbubbles in vascular medecine]
Erdmann A., Ney B., Alatri A., Calanca L., Mazzolai L., 2016/12/07. Revue medicale suisse, 12 (542) pp. 2131-2134. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_080AE95A27BE]
 
An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases.
Smith V., Beeckman S., Herrick A.L., Decuman S., Deschepper E., De Keyser F., Distler O., Foeldvari I., Ingegnoli F., Müller-Ladner U. et al., 2016/05. Rheumatology, 55 (5) pp. 883-890. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_07AC5B279648]
 
Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry.
Frasson S., Gussoni G., Di Micco P., Barba R., Bertoletti L., Nuñez M.J., Valero B., Samperiz A.L., Rivas A., Monreal M. et al., 2016/04. Journal of thrombosis and thrombolysis, 41 (3) pp. 404-412.
[DOI][Pmid][serval:BIB_B3955A0FB6A5]
 
Thrombopénie induite par l'héparine et syndrome de Trousseau
Katchaluba Maria, Glauser Frédéric, Holzer Thomas, Mazzolai Lucia, Alatri Adriano, 2016/03/01. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (09).
[DOI][serval:BIB_A025BD8B8F97]
 
Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry.
Jiménez D., de Miguel-Díez J., Guijarro R., Trujillo-Santos J., Otero R., Barba R., Muriel A., Meyer G., Yusen R.D., Monreal M. et al., 2016/01/19. Journal of the American College of Cardiology, 67 (2) pp. 162-170.
[DOI][Pmid][serval:BIB_2A7244D705DD]
 
Accuracy of in-patients ankle-brachial index measurement by medical students.
Monti M., Calanca L., Alatri A., Mazzolai L., 2016. Vasa. Zeitschrift Für Gefässkrankheiten, 45 (1) pp. 43-48. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5E4A96442855]
 
Les nouveaux anticoagulants oraux directs. Leurs interactions médicamenteuses et leur utilisation dans des situations particulières
Alatri Adriano, Mazzolai Lucia, 2016/01. info@herz+gefäss.
[serval:BIB_99F4678DABFC]
 
Les nouveaux anticoagulants oraux.
Alatri Adriano, Mazzolai Lucia, 2016. La Gazette Médicale - info@gériatrie 6 pp. 15-17.
[serval:BIB_B88E94274ACC]
 
Myocardial infarction after ultrasoundguided foam sclerotherapy for varicose veins--a case report and review of the literature of a rare but serious adverse event.
Engelberger R.P., Ney B., Clair M., Dabiri A., Alatri A., Mazzolai L., Kern P., 2016. Vasa. Zeitschrift Für Gefässkrankheiten, 45 (3) pp. 255-258. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_27F916684E95]
 
Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.
Alatri A., Schoepfer A., Fournier N., Engelberger R.P., Safroneeva E., Vavricka S., Biedermann L., Calanca L., Mazzolai L., Swiss IBD Cohort Study Group, 2016. Scandinavian Journal of Gastroenterology, 51 (10) pp. 1200-1205. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C1105D8E5054]
2015
 
Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.
Portillo J., de la Rocha I.V., Font L., Braester A., Madridano O., Peromingo J.A., Apollonio A., Pagán B., Bascuñana J., Monreal M. et al., 2015/12. Thrombosis research, 136 (6) pp. 1199-1203. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FACFF5457A1C]
Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice.
Giorgi-Pierfranceschi M., Di Micco P., Cattabiani C., Guida A., Pagán B., Morales M.del V., Salgado E., Suriñach J.M., Tolosa C., Monreal M. et al., 2015/11. Medicine, 94 (47) pp. e1915. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4BCDB161AA2A]
 
A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis.
Baumann Kreuziger L., Cote L., Verhamme P., Greenberg S., Caprini J., Muñoz F.J., Valle R., Monreal Bosch M., RIETE Investigators, 2015/07. Journal of vascular surgery. Venous and lymphatic disorders, 3 (3) pp. 243-50.e1.
[DOI][Pmid][serval:BIB_02E1A6174C1E]
 
Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism.
Madridano O., del Toro J., Lorenzo A., Martín M., Gómez Cerezo J., Hernández L., Prandoni P., Monreal M., RIETE Investigators, 2015/04. Journal of vascular surgery. Venous and lymphatic disorders, 3 (2) pp. 135-41.e1.
[DOI][Pmid][serval:BIB_F620E5CE0C65]
 
A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs.
Trujillo-Santos J., Lozano F., Lorente M.A., Adarraga D., Hirmerova J., Del Toro J., Mazzolai L., Barillari G., Barrón M., Monreal M. et al., 2015. American Journal of Medicine, 128 (1) pp. 90.e9-90.e15. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A3669171DD27]
 
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity.
Rosa-Salazar V., Trujillo-Santos J., Díaz Peromingo J.A., Apollonio A., Sanz O., Malý R., Muñoz-Rodriguez F.J., Serrano J.C., Soler S., Monreal M. et al., 2015. Journal of Thrombosis and Haemostasis : Jth, 13 (7) pp. 1274-1278. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4E95F9F3518B]
 
Artériopathies non athéromateuses des membres inférieurs [Non atherosclerotic arterial disease of lower limbs].
Calanca L., Alatri A., Depairon M., Engelberger R.P., Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) pp. 352, 354-352, 356.
[Pmid][serval:BIB_853C0E755E03]
 
Duration of anticoagulation after venous thromboembolism in real world clinical practice.
Ageno W., Samperiz A., Caballero R., Dentali F., Di Micco P., Prandoni P., Becattini C., Uresandi F., Verhamme P., Monreal M. et al., 2015. Thrombosis Research, 135 (4) pp. 666-672. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B3F62364D1D2]
Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
Farge D., Trujillo-Santos J., Debourdeau P., Bura-Riviere A., Rodriguez-Beltrán E.M., Nieto J.A., Peris M.L., Zeltser D., Mazzolai L., Hij A. et al., 2015. Medicine, 94 (32) pp. e1235. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_53A318821B08]
 
Fondaparinux in the initial and long-term treatment of venous thromboembolism.
Pesavento R., Amitrano M., Trujillo-Santos J., Di Micco P., Mangiacapra S., López-Jiménez L., Falgá C., García-Bragado F., Piovella C., Prandoni P. et al., 2015. Thrombosis Research, 135 (2) pp. 311-317. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3CA9EFD56CCA]
 
Gender differences in cancer patients with acute venous thromboembolism.
Martín-Martos F., Trujillo-Santos J., Barrón M., Vela J., Javier Marchena P., Braester A., Hij A., Hernández-Blasco L., Verhamme P., Manuel M. et al., 2015. Thrombosis Research, 135 Suppl 1 pp. S12-S15.
[DOI][WoS][Pmid][serval:BIB_130AF90F60B8]
 
Identification of Low-Risk Patients with Acute Symptomatic Pulmonary Embolism for Outpatient Therapy.
Maestre A., Trujillo-Santos J., Riera-Mestre A., Jiménez D., Di Micco P., Bascuñana J., Vela J.R., Peris L., Malfante P.C., Monreal M. et al., 2015. Annals of the American Thoracic Society, 12 (8) pp. 1122-1129. Peer-reviewed.
[DOI][Pmid][serval:BIB_518589DC9FC9]
 
Initiation of rivaroxaban in patients with nonvalvular atrial fibrillation at the primary care level: the Swiss Therapy in Atrial Fibrillation for the Regulation of Coagulation (STAR) Study.
Engelberger R.P., Noll G., Schmidt D., Alatri A., Frei B., Kaiser W.E., Kucher N., 2015. European Journal of Internal Medicine, 26 (7) pp. 508-514. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AD86B7A32BB2]
Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
Mahé I., Sterpu R., Bertoletti L., López-Jiménez L., Mellado Joan M., Trujillo-Santos J., Ballaz A., Hernández Blasco L.M., Marchena P.J., Monreal M. et al., 2015. Plos One, 10 (6) pp. e0128741. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5235AEC57B36]
Quelle prise en charge pour une suspicion de thrombose veineuse profonde des membres inférieurs [Suspicion of lower limb deep vein thrombosis: update on diagnosis and treatment].
Erdmann A., Alatri A., Engelberger R.P., Depairon M., Calanca L., Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) pp. 337-341. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_21F1CA9CE78F]
 
The impact of disseminated intravascular coagulation on the outcome of cancer patients with venous thromboembolism.
Spiezia L., Campello E., Trujillo-Santos J., Piovella C., Brenner B., Monreal M., Prandoni P., RIETE Investigators, 2015. Blood Coagulation and Fibrinolysis : An International Journal In Haemostasis and Thrombosis, 26 (6) pp. 709-711. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9BB20E86DFD0]
Traitement percutané de la thrombose veineuse profonde aiguë [Catheter-based treatment for acute deep vein thrombosis].
Engelberger R.P., Alatri A., Qanadli S.D., Calanca L., Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) pp. 348-351. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1EA0F8BBB18F]
 
Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis.
Engelberger R.P., Spirk D., Willenberg T., Alatri A., Do D.D., Baumgartner I., Kucher N., 2015. Circulation. Cardiovascular Interventions, 8 (1) pp. e002027. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DEC8C2872B6D]
 
Venous thromboembolism in patients immobilised at home.
López-Reyes R., Nauffal D., Ballester M., Martín-Antorán J.M., de Sousa M.S., Riera-Mestre A., Ruiz-Ruiz J., Fernández-Capitán C., Uresandi F., Monreal M. et al., 2015. European Respiratory Journal, 45 (6) pp. 1728-1731. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_121694041792]
2014
 
Sex differences in patients receiving anticoagulant therapy for venous thromboembolism.
Blanco-Molina A., Enea I., Gadelha T., Tufano A., Bura-Riviere A., Di Micco P., Bounameaux H., González J., Villalta J., Monreal M. et al., 2014/10. Medicine, 93 (17) pp. 309-317. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3E6684B47766]
 
Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy.
Tzoran I., Brenner B., Sakharov G., Trujillo-Santos J., Lorenzo A., Madridano O., López-Sáez J.B., Monreal M., RIETE investigators, 2014. European Journal of Internal Medicine, 25 (9) pp. 821-825. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D6816FBC4487]
 
D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer.
Maestre A., Trujillo-Santos J., Visoná A., Lobo J.L., Grau E., Malý R., Duce R., Monreal M., RIETE Investigators, 2014. Thrombosis Research, 133 (3) pp. 384-389. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3CB61DE2F6C6]
 
Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs.
Lozano F., Trujillo-Santos J., Barrón M., Gallego P., Babalis D., Santos M., Falgá C., Monreal M., RIETE Investigators, 2014. Journal of Vascular Surgery, 59 (5) pp. 1362-7.e1. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AC5D4E40116A]
 
Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry.
Cote L.P., Greenberg S., Caprini J.A., Stone J., Arcelus J.I., López-Jiménez L., Rosa V., Schellong S., Monreal M., RIETE Investigators, 2014. Clinical and Applied Thrombosis/hemostasis, 20 (8) pp. 772-778. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ECE77A86D018]
2013
 
The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
Cosmi B., Legnani C., Pengo V., Ghirarduzzi A., Testa S., Poli D., Prisco D., Tripodi A., Palareti G., PROLONG Investigators (on behalf of FCSA Italian Federation of Anticoagulation Clinics), 2013/03. Thrombosis and haemostasis, 109 (3) pp. 510-516. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9C50EB2E19A6]
 
A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer.
den Exter P.L., Gómez V., Jiménez D., Trujillo-Santos J., Muriel A., Huisman M.V., Monreal M., Registro Informatizado de la Enfermedad TromboEmbólica (RIETE) Investigators, 2013. Chest, 143 (1) pp. 138-145.
[DOI][WoS][Pmid][serval:BIB_51871E808374]
 
Deep vein thrombosis of the penis: an unusual but severe complication of prostatic abscess.
Calanca L., Alatri A., Schaller M.D., Sermier A., Mazzolai L., 2013. Vasa. Zeitschrift Für Gefässkrankheiten, 42 (3) pp. 214-217.
[DOI][WoS][Pmid][serval:BIB_4DEDE37A5B18]
 
Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
Lecumberri R., Alfonso A., Jiménez D., Fernández Capitán C., Prandoni P., Wells P.S., Vidal G., Barillari G., Monreal M., RIETE investigators, 2013. Thrombosis and Haemostasis, 110 (4) pp. 834-843.
[DOI][WoS][Pmid][serval:BIB_9BC370C12A38]
 
Factors associated with elevated pulmonary arterial pressure levels on the echocardiographic assessment in patients with prior pulmonary embolism.
Otero R., Elías T., Jara L., Trujillo-Santos J., Bertoletti L., Nauffal D., Ruiz-Ruiz J., Blanco-Molina Á., Monreal M., RIETE investigators, 2013. Thrombosis Research, 131 (5) pp. e191-e195.
[DOI][WoS][Pmid][serval:BIB_8ACB85640E15]
 
Low-molecular-weight or unfractionated heparin in venous thromboembolism: the influence of renal function.
Trujillo-Santos J., Schellong S., Falga C., Zorrilla V., Gallego P., Barrón M., Monreal M., RIETE Investigators, 2013. American Journal of Medicine, 126 (5) pp. 425-434.e1.
[DOI][WoS][Pmid][serval:BIB_BABD967F0F5B]
 
Syndrome de l'artère poplitée piégée [Popliteal artery entrapment syndrome].
Calanca L., Glauser F., Alatri A., Mazzolai L., 2013. Revue Médicale Suisse, 9 (372) pp. 311-314.
[Pmid][serval:BIB_77800E3F2AF6]
 
Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism.
Nieto J.A., Solano R., Trapero Iglesias N., Ruiz-Giménez N., Fernández-Capitán C., Valero B., Tiberio G., Bura-Riviere A., Monreal M., RIETE Investigators, 2013. Thrombosis Research, 132 (2) pp. 175-179.
[DOI][WoS][Pmid][serval:BIB_179561E54B8C]
2012
 
Aspirin for preventing the recurrence of venous thromboembolism.
Becattini C., Agnelli G., Schenone A., Eichinger S., Bucherini E., Silingardi M., Bianchi M., Moia M., Ageno W., Vandelli M.R. et al., 2012. New England Journal of Medicine, 366 (21) pp. 1959-1967.
[DOI][WoS][Pmid][serval:BIB_42E530ECCC83]
 
Prise en charge du syndrome post-thrombotique [Management of post-thrombotic syndrome].
Alatri A., Mazzolai L., 2012. Praxis, 101 (13) pp. 843-848.
[DOI][Pmid][serval:BIB_54A705FE0D5E]
 
Prévention du syndrome post-thrombotique [Prevention of post-thrombotic syndrome].
Alatri A., Calanca L., Tomson D., Mazzolai L., 2012. Revue Médicale Suisse, 8 (327) pp. 311-314.
[Pmid][serval:BIB_7A2D7403CCA9]
 
Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - a European Perspective.
Alatri A., Armstrong A.E., Greinacher A., Koster A., Kozek-Langenecker S.A., Lancé M.D., Link A., Nielsen J.D., Sandset P.M., Spanjersberg A.J. et al., 2012. Thrombosis Research, 129 (4) pp. 426-433.
[DOI][WoS][Pmid][serval:BIB_EA604C5529C3]
 
Rééducation vasculaire du patient artériopathe [Vascular rehabilitation of patients suffering from peripheral arterial disease].
Calanca L., Alatri A., Junod N., Theurillat C., Mazzolai L., 2012. Revue Médicale Suisse, 8 (327) pp. 302-305.
[Pmid][serval:BIB_F8421AFF19CB]
 
The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
Ageno W., Cosmi B., Ghirarduzzi A., Santoro R., Bucherini E., Poli D., Prisco D., Alatri A., Pengo V., Galli L. et al., 2012. American Journal of Hematology, 87 (7) pp. 713-715.
[DOI][WoS][Pmid][serval:BIB_DDE2FBEAEAE9]
2011
 
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy.
Giampaolo A., Abbonizio F., Puopolo M., Arcieri R., Mannucci P.M., Italian Association of Haemophilia Centres, Hassan H.J., Accorsi A., Ettorre P.C., Schiavoni M. et al., 2011. Transfusion Medicine, 21 (4) pp. 280-284.
[DOI][WoS][Pmid][serval:BIB_7FBD40099D62]
 
International registry on splanchnic vein thrombosis: description of the study population
Ageno W., Schulman S., Riva N., Bang S.M., Sartori M.T., Beyer J., Barillari G., Grandone E., Malato A., Santoro R. et al., 2011. p. 304 dans 23th Congress of the International Society on Thrombosis and Haemostasis, 57th Annual SSC Meeting, Journal of Thrombosis and Haemostasis.
[serval:BIB_54060B832863]
 
Risque thrombotique sous procréation médicalement assistée [Thrombotic risk in assisted reproductive technology].
Alatri A., Tribout B., Gencer B., Calanca L., Mazzolai L., 2011. Revue Médicale Suisse, 7 (281) pp. 357-360.
[Pmid][serval:BIB_9711B1BCC641]
 
Thrombose veineuse superficielle: quelles nouveautés dans la prise en charge [Superficial vein thrombosis: what's new in the management?].
Gencer B., Tribout B., Alatri A., Mazzolai L., Calanca L., 2011. Revue Médicale Suisse, 7 (314) pp. 2098-2101.
[Pmid][serval:BIB_E21B08E2B5E0]
2010
 
Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
Cosmi B., Legnani C., Tosetto A., Pengo V., Ghirarduzzi A., Testa S., Prisco D., Poli D., Tripodi A., Palareti G., 2010. Thrombosis and Haemostasis, 103 (6) pp. 1152-1160.
[DOI][WoS][Pmid][serval:BIB_8FFB2346B7A8]
 
Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
Cosmi B., Legnani C., Iorio A., Pengo V., Ghirarduzzi A., Testa S., Poli D., Tripodi A., Palareti G., PROLONG Investigators (on behalf of FCSA Italian Federation of Anticoagulation Clinics), 2010. European Journal of Vascular and Endovascular Surgery, 39 (3) pp. 356-365.
[DOI][WoS][Pmid][serval:BIB_E7A4C5DD01BF]
 
Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension.
Cosmi B., Legnani C., Tosetto A., Pengo V., Ghirarduzzi A., Testa S., Prisco D., Poli D., Tripodi A., Palareti G. et al., 2010. Journal of Thrombosis and Haemostasis, 8 (9) pp. 1933-1942.
[DOI][WoS][Pmid][serval:BIB_56F282127F83]
The cost of inappropriateness of coagulation testing [I costi dell'inappropriatezza in coagulazione]
Martini G., Del Bono R., Volpi R., Bontempi F., Jaeger A., Morandini R., Testa S., Pedrini S, Paoletti O., Alatri A., 2010. Rivista Italiana della Medicina di Laboratorio, 6 (1) pp. 20-27.
[URN][serval:BIB_817C1FA12C91]
 
Treatment with argatroban in one haemodialysed patient with a heparin-induced thrombocytopenia and thrombotic complications.
Alatri A., Foramitti M., Paoletti O., Zimmermann A., Testa S., 2010. Internal and Emergency Medicine, 5 (4) pp. 359-360.
[DOI][WoS][Pmid][serval:BIB_D9D4AB5A0E1E]
2009
 
Assessment of the risk of bleeding in patients undergoing surgery or invasive procedures: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).
Cosmi B., Alatri A., Cattaneo M., Gresele P., Marietta M., Rodeghiero F., Tripodi A., Ansaloni L., Fusari M., Taddei S. et al., 2009. Thrombosis Research, 124 (5) pp. e6-e12. Peer-reviewed.
[DOI][Pmid][serval:BIB_4C681D537FE4]
 
Evidence-based recommendations on the treatment of von Willebrand disease in Italy.
Mannucci P.M., Franchini M., Castaman G., Federici A.B., Italian Association of Hemophilia Centers, 2009. Blood Transfusion = Trasfusione Del Sangue, 7 (2) pp. 117-126. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4BBCE8D8B7A7]
 
Haemostatic assessment of the preoperative risk of bleeding. Comparison of the guidelines of NICE and of the Italian Society for Thrombosis and Haemostasis (SISET: Società Italiana per lo Studio dell'Emostasi e Trombosi)
Cosmi B., Alatri A., Cattaneo M., Gresele P., Marietta M., Rodeghiero F., Tripodi A., Ansaloni L., Fusari M., Taddei S., 2009. Rivista Italiana della Medicina di Laboratorio, 5 (2) pp. 166-168.
[serval:BIB_E383DC6D6B86]
Haemostatic assessment of the preoperative risk of bleeding. Comparison of the guidelines of NICE and of the Italian Society for Thrombosis and Haemostasis [Gli screening emocoagulativi per la valutazione del rischio emorragico preoperatorio. Il confronto tra linee guida NICE e SISET]
Cosmi B., Alatri A., Cattaneo M., Greseled P., Mariettae M., Rodeghierof F., Tripodig A., Ansalonih L., Fusarii M., Taddeii S., 2009. Rivista Italiana della Medicina di Laboratorio, 5 (2) pp. 166-168.
[serval:BIB_51FB3BCE44D5]
Oral anticoagulant therapy : better anticoagulation clinics or routine medical care [TAO: meglio la Medicina di Base o i Centri di Sorveglianza?]
Testa S., Paoletti O., Alatri A., Zimmermann A., Bassi L., 2009. Rivista Italiana della Medicina di Laboratorio, 5 (2) pp. 160-165.
[serval:BIB_AD4E2693C847]
 
Oral anticoagulant therapy: Better anticoagulation clinics or routine medical care?
Testa S., Paoletti O., Alatri A., Zimmermann A., Bassi L., 2009. Rivista Italiana della Medicina di Laboratorio, 5 (2) pp. 160-165.
[serval:BIB_33B008841B4E]
 
The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study.
Fagnani D., Bertolini A., Catena L., Tomirotti M., Visini M., Alatri A., De Paoli A., Aondio G.M., Milani M., Arpaia G. et al., 2009. Blood Coagulation and Fibrinolysis, 20 (1) pp. 35-40. Peer-reviewed.
[DOI][Pmid][serval:BIB_4F18224ED003]
 
Tromboprofilassi e protocolli di management dei pazienti in terapia antitrombotica nel day surgery
Alatri Adriano, Palareti Gualtiero, 2009. Day Surgery.
[serval:BIB_828C2913A552]
 
Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study.
Cosmi B., Legnani C., Tosetto A., Pengo V., Ghirarduzzi A., Alatri A., Prisco D., Poli D., Tripodi A., Palareti G., 2009. Journal of Thrombosis and Thrombolysis, 28 (4) pp. 381-388. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_520FF5DF67C0]
2008
 
D-dimer testing and recurrent venous thromboembolism after unprovoked pulmonary embolism: A post-hoc analysis of the prolong extension study.
Pengo V., Palareti G., Cosmi B., Legnani C., Tosetto A., Alatri A., Marzot F., Pegoraro C., Cucchini U., Iliceto S. et al., 2008. Thrombosis and Haemostasis, 100 (4) pp. 718-721.
[WoS][Pmid][serval:BIB_45B849C8BA84]
 
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis.
Iorio A., Oliovecchio E., Morfini M., Mannucci P.M., Association of Italian Hemophilia Centres Directors, 2008. Haemophilia, 14 (3) pp. 444-453. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B4D8030D5BC1]
2007
 
Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis.
Fagnani D., Franchi R., Porta C., Pugliese P., Borgonovo K., Bertolini A., Duro M., Ardizzoia A., Filipazzi V., Isa L. et al., 2007. Annals of Oncology, 18 (3) pp. 551-555. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_465BF5E49929]
2006
Coagulation : screening tests and diagnostic protocols [Coagulazione: test di screening e percorsi diagnostici]
Testa S., Alatri A., Morstabilini G., Paoletti O., 2006. Rivista Italiana della Medicina di Laboratorio, 2 (1) pp. 103-106.
[URN][serval:BIB_9BC58E460342]
 
D-dimer testing to determine the duration of anticoagulation therapy.
Palareti G., Cosmi B., Legnani C., Tosetto A., Brusi C., Iorio A., Pengo V., Ghirarduzzi A., Pattacini C., Testa S. et al., 2006. New England Journal of Medicine, 355 (17) pp. 1780-1789. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0503E6044046]
 
Reorganisation of an anticoagulation clinic using a telemedicine system: description of the model and preliminary results.
Testa S., Alatri A., Paoletti O., Morstabilini G., Medagliani M.A., Denti N., Martellenghi E., 2006. Internal and Emergency Medicine, 1 (1) pp. 24-29. Peer-reviewed.
[WoS][Pmid][serval:BIB_C9DACA028C1C]
2005
 
Telemedicina per la gestione dei pazienti in terapia anticoagulante orale (TAO)
Alatri Adriano, 2005. Riv Med Lab.
[serval:BIB_32D28ADAD4DC]
 
The role of the Laboratory in antithrombotic treatment monitoring : Is there something new? [Il ruolo del Laboratorio nel monitoraggio delle terapie antitrombotiche: c'è qualcosa di nuovo?]
Testa S., Antonucci G., Martini G., Pedrini S., Intra E.F., Alatri A., 2005. pp. 94-96 dans SIMeL, Congresso della Società Italiana Medicina di Laboratorio, Rivista Italiana della Medicina di Laboratorio.
[serval:BIB_3056248D2118]
2004
 
Il counselling per le trombofilie
Alatri Adriano, 2004/11/01. Riv. Med. Labor.
[serval:BIB_D9E966F2FC78]
 
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.
Pengo V., Lensing A.W., Prins M.H., Marchiori A., Davidson B.L., Tiozzo F., Albanese P., Biasiolo A., Pegoraro C., Iliceto S. et al., 2004. New England Journal of Medicine, 350 (22) pp. 2257-2264. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FE2CE08D9C51]
 
Screening for thrombophilia [Gli screening per trombofilia]
Testa S, Antonucci G, Intra E., Martini G., Pedrini S., Alatri A., 2004. pp. 118-120 dans SIMeL, Società Italiana Medicina di Laboratorio, Proceedings Laboratory Appropriate Use, Rivista Italiana della Medicina di Laboratorio.
[serval:BIB_8C2A00142F33]
 
Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
Prandoni P., Carnovali M., Marchiori A., Galilei Investigators, 2004. Archives of Internal Medicine, 164 (10) pp. 1077-1083. Peer-reviewed.
[DOI][Pmid][serval:BIB_C7818216A62D]
 
Thrombophilia counseling
Antonucci G., Testa S., Intra E. F., Martini G., Pedrini S., Alatri A., Bader R., Manzato F., 2004. Rivista di Medicina di Laboratorio, 5 (3 SUPPL.) pp. 157-159.
[serval:BIB_098B4DD36B45]
2003
 
Preanalytic variables in the study of hemostasis
Testa Sophie, Antonucci Giovanna, Martini Giuliana, Pedrini Simona, Intra Ettore, Alatri Adriano, Bader Rossella, Manzato Franco, 2003. Riv. Med. Lab., 4 (S.1) pp. 81-84.
[serval:BIB_50852DA0309B]
2002
 
Accreditation standard for surveillance center for patients undergoing oral anticoagulant therapy
Testa Sophie, Iorio Alfonso, Alatri Adriano, Parisoli Antonella, Ghirarduzzi Angelo, Berrettini Mauro, 2002. Riv Med Labor, 3 (2 - S1) pp. 52-56.
[serval:BIB_A52067CB0167]
2001
 
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
Agnelli G., Prandoni P., Santamaria M.G., Bagatella P., Iorio A., Bazzan M., Moia M., Guazzaloca G., Bertoldi A., Tomasi C. et al., 2001. New England Journal of Medicine, 345 (3) pp. 165-169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7762245C7346]
2000
 
Tromboembolismo venoso e neoplasia [Venous thromboembolism and neoplasms].
Alatri A., Carnovali M., Prandoni P., 2000. Annali Italiani di Medicina Interna, 15 (2) pp. 156-165. Peer-reviewed.
[Pmid][serval:BIB_1B62A897AD59]
1999
 
Antibody response to 1995-1996 influenza vaccine in institutionalized and non-institutionalized elderly women.
Iorio A.M., Alatri A., Camilloni B., Neri M., Baglio G., Donatelli I., 1999. Gerontology, 45 (1) pp. 31-38.
[WoS][Pmid][serval:BIB_58957386D628]
 
Anticoagulation for venous thromboembolism.
Bucciarelli P., Alatri A., Moia M., 1999. New England Journal of Medicine, 341 (7) pp. 539; author reply 540.
[DOI][Pmid][serval:BIB_A9A07CF9768C]
 
Subcutaneous heparin for deep venous thrombosis.
Alatri A., Bucciarelli P., Moia M., 1999. Annals of Internal Medicine, 130 (12) p. 1027.
[WoS][Pmid][serval:BIB_A384AEE24077]
1998
 
Budd-Chiari syndrome in a patient heterozygous for the G20210A mutation of the prothrombin gene.
Bucciarelli P., Franchi F., Alatri A., Bettini P., Moia M., 1998. Thrombosis and Haemostasis, 79 (2) pp. 445-446.
[WoS][Pmid][serval:BIB_FBB7A2098ACC]
 
Choice of end-points in assessing the efficacy of post-discharge prophylaxis for venous thromboembolism.
Alatri A., Iorio A., Agnelli G., 1998. Thrombosis and Haemostasis, 79 (1) p. 234.
[WoS][Pmid][serval:BIB_74C62D439ADB]
 
D-dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep vein thrombosis: prospective cohort study. The Multicentre Italian D-dimer Ultrasound Study Investigators Group.
Bernardi E., Prandoni P., Lensing A.W., Agnelli G., Guazzaloca G., Scannapieco G., Piovella F., Verlato F., Tomasi C., Moia M. et al., 1998. BMJ, 317 (7165) pp. 1037-1040. Peer-reviewed.
[WoS][Pmid][serval:BIB_9E880F13423A]
 
Homozygous G20210A prothrombin gene mutation without thromboembolic events: a case report.
Alatri A., Franchi F., Moia M., 1998. Thrombosis and Haemostasis, 80 (6) pp. 1028-1029.
[WoS][Pmid][serval:BIB_45C37BEC9E59]
 
Occult cancer and venous thromboembolism.
Alatri A., Bucciarelli P., Moia M., Mannucci P.M., 1998. Thrombosis and Haemostasis, 80 (2) pp. 347-348.
[WoS][Pmid][serval:BIB_E51B3FF611AA]
 
The post-thrombotic syndrome in young women: retrospective evaluation of prognostic factors.
Biguzzi E., Mozzi E., Alatri A., Taioli E., Moia M., Mannucci P.M., 1998. Thrombosis and Haemostasis, 80 (4) pp. 575-577. Peer-reviewed.
[WoS][Pmid][serval:BIB_A855B8254619]
 
Venous thromboembolism after laparoscopic surgery: two case reports and review of the literature.
Alatri A., Tronci M., Bucciarelli P., Moia M., 1998. Annali Italiani di Medicina Interna, 13 (1) pp. 53-55.
[Pmid][serval:BIB_5C5C50BDA2C8]
1997
 
Aneurisma bilaterale della vena iliaca commune: descrizione di un caso clinico [Bilateral aneurysm of the common iliac vein: a case report].
Alatri A., Radicchia S., 1997. Annali Italiani di Medicina Interna, 12 (2) pp. 92-93.
[Pmid][serval:BIB_6824FA41886A]
 
Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users.
Iorio A.M., Alatri A., Francisci D., Preziosi R., Neri M., Donatelli I., Castrucci M.R., Biasio L.R., Tascini C., Iapoce R. et al., 1997. Vaccine, 15 (1) pp. 97-102.
[WoS][Pmid][serval:BIB_172AAD80FD6F]
 
Venous thromboebolism
Alatri A., Moia M., 1997. Ospedale Maggiore, 91 (3) pp. 246-253.
[serval:BIB_21AF0AB9F477]
1996
 
Possible correlation between low antigenic drift of A(H1N1) influenza viruses and induction of HI antibodies.
Iorio A.M., Zei T., Neri M., Alatri A., 1996. European Journal of Epidemiology, 12 (6) pp. 589-594. Peer-reviewed.
[WoS][Pmid][serval:BIB_37426E1070BC]
1994
 
Plasma thrombin neutralization assay: pharmacokinetic applications.
Iorio A., Alatri A., Mazzolai L., Agnelli G., 1994. Seminars In Thrombosis and Hemostasis, 20 (3) pp. 266-273.
[DOI][WoS][Pmid][serval:BIB_0815FE106026]
1993
 
Enhancement of endogenous fibrinolysis upon subcutaneous administration of DDAVP and heparin
Oosterhof K., Van der Meulen A., Alatri A., Levi M., Ten Caten J.W., Agnelli G., 1993. Thrombotic and Haemorrhagic Disorders, 8 (1) pp. 19-23.
[serval:BIB_D094666786C7]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University